What are your key takeaways from this study, and how do the results influence your perspective on long-term options for the treatment of atopic dermatitis? In your current practice, where does ...

The Revolutionizing Atopic Dermatitis (RAD) Conference 2025 takes place June 6–7 at the DoubleTree by Hilton Hotel Nashville Downtown Held in partnership with HCPLive® and Dermatology Times ...

In a post-hoc analysis, dupilumab improved symptoms of atopic dermatitis (AD) in young children ages 6 months to 5 years. Youngsters with associated comorbidities such as asthma, allergic rhinitis ...

Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for targeted treatments and achieving long-term remission. Raj Chovatiya ...

Medscape Medical News, April 09, 2025 Early-Onset Atopic Dermatitis Raises Uveitis Risk in Kids A cohort study finds children with early-onset atopic dermatitis to be at increased risk for uveitis ...

In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from presentations at the American Academy of Dermatology meeting.

The atopic dermatitis app will launch first in the UK, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later in 2022. Image Phil Taylor ...

Johnson & Johnson has reached an agreement to acquire a bispecific antibody for atopic dermatitis (AD) from Numab Therapeutics in an all-cash deal valued at $1.25 billion. Under the terms of the ...

If you have atopic dermatitis (AD), also known as eczema, then you know the struggle: You climb into bed ready to catch some zzz's, but can't sleep because of the intense, relentless itching.

Block, MD Living with atopic dermatitis “can genuinely feel uncomfortable to be in your own skin," as described by Ethan Chee, a master of social work student at Columbia University. Atopic ...